Lv1
22 积分 2022-02-08 加入
NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer
16天前
已完结
Targeting SERPINB3–MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy
16天前
已完结
Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702
4个月前
已完结
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer
4个月前
已完结
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
4个月前
已完结
KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers
4个月前
已完结
Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties
4个月前
已完结
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
4个月前
已完结
Optimizing KRAS Therapeutics for Non–Small Cell Lung Cancer
4个月前
已完结
Response and Resistance to RAS Inhibition in Cancer
4个月前
已完结
皖公网安备34019202002308
